What they were paid
OptimizeRx Director Compensation Table · all 4 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $54,000 | $149,994 | — | — | $203,994 |
| FY2024 | $54,000 | $149,999 | $0 | $0 | $203,999 |
| FY2023 | $54,000 | $150,010 | $0 | $0 | $204,010 |
| FY2022 | $54,000 | $150,026 | $0 | $0 | $204,026 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OptimizeRx Corp DEF 14A filed April 30, 2026, accession 0001213900-26-049698, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025OptimizeRx pays directors a $40,000 cash retainer and $150,000 in RSUs.
Committees
FY2025 · as the proxy prints themCompensation (Chair) · Nominating/Governance
The rest of the OptimizeRx board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Catherine Klema | Independent Director | $227,994 |
| Gregory Wasson | Independent Director | $200,994 |
| Lynn O'Connor Vos | Independent Director | $268,994 |
| Mariyamma Varghese Presti | Independent Director | — |
| Patrick Spangler | Independent Director | $234,994 |
| Stephen Silvestro | Director | $0 |
The full OptimizeRx compensation record
free company briefThis page is one director within OptimizeRx's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat